Suppr超能文献

射血分数保留和降低的心力衰竭预测:心力衰竭亚型国际协作研究

Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes.

作者信息

Ho Jennifer E, Enserro Danielle, Brouwers Frank P, Kizer Jorge R, Shah Sanjiv J, Psaty Bruce M, Bartz Traci M, Santhanakrishnan Rajalakshmi, Lee Douglas S, Chan Cheeling, Liu Kiang, Blaha Michael J, Hillege Hans L, van der Harst Pim, van Gilst Wiek H, Kop Willem J, Gansevoort Ron T, Vasan Ramachandran S, Gardin Julius M, Levy Daniel, Gottdiener John S, de Boer Rudolf A, Larson Martin G

机构信息

From the Cardiovascular Research Center, Massachusetts General Hospital (J.E.H.); Cardiovascular Medicine Section, Department of Medicine (R.S.) and Section of Preventive Medicine and Epidemiology (R.S.V.), Boston University School of Medicine, MA; National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, MA (J.E.H., R.S.V., D.L., M.G.L.); Department of Mathematics and Statistics, Boston University, MA (D.E., M.G.L.); Department of Cardiology (F.P.B., H.L.H., P.v.d.H., W.H.v.G., R.A.d.B.) and Division of Nephrology, Department of Internal Medicine (R.T.G.), University Medical Center Groningen, The Netherlands; Department of Medicine and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (J.R.K.); Division of Cardiology (S.J.S.), Department of Medicine (C.C., K.L.), and Department of Preventive Medicine (C.C., K.L.), Northwestern University Feinberg School of Medicine, Chicago, IL; Cardiovascular Health Research Unit, Department of Medicine, Department of Epidemiology, and Department of Health Services (B.M.P.) and Department of Biostatistics (T.M.B.), University of Washington; Group Health Research Institute, Group Health Cooperative, Seattle, WA (B.M.P.); Institute for Clinical Evaluative Sciences, Toronto, Canada (D.S.L.); University Health Network, University of Toronto, Canada (D.S.L.); Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University, Baltimore, MD (M.J.B.); Department of Medicine, Hackensack University Medical Center and Rutgers New Jersey Medical School, Hackensack, NJ (J.M.G.); Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands (W.J.K.); Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (D.L.); and Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (J.S.G.). jho

From the Cardiovascular Research Center, Massachusetts General Hospital (J.E.H.); Cardiovascular Medicine Section, Department of Medicine (R.S.) and Section of Preventive Medicine and Epidemiology (R.S.V.), Boston University School of Medicine, MA; National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, MA (J.E.H., R.S.V., D.L., M.G.L.); Department of Mathematics and Statistics, Boston University, MA (D.E., M.G.L.); Department of Cardiology (F.P.B., H.L.H., P.v.d.H., W.H.v.G., R.A.d.B.) and Division of Nephrology, Department of Internal Medicine (R.T.G.), University Medical Center Groningen, The Netherlands; Department of Medicine and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (J.R.K.); Division of Cardiology (S.J.S.), Department of Medicine (C.C., K.L.), and Department of Preventive Medicine (C.C., K.L.), Northwestern University Feinberg School of Medicine, Chicago, IL; Cardiovascular Health Research Unit, Department of Medicine, Department of Epidemiology, and Department of Health Services (B.M.P.) and Department of Biostatistics (T.M.B.), University of Washington; Group Health Research Institute, Group Health Cooperative, Seattle, WA (B.M.P.); Institute for Clinical Evaluative Sciences, Toronto, Canada (D.S.L.); University Health Network, University of Toronto, Canada (D.S.L.); Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University, Baltimore, MD (M.J.B.); Department of Medicine, Hackensack University Medical Center and Rutgers New Jersey Medical School, Hackensack, NJ (J.M.G.); Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands (W.J.K.); Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD (D.L.); and Department of Medicine, University of Maryland School of Medicine, Baltimore, MD (J.S.G.).

出版信息

Circ Heart Fail. 2016 Jun;9(6). doi: 10.1161/CIRCHEARTFAILURE.115.003116.

Abstract

BACKGROUND

Heart failure (HF) is a prevalent and deadly disease, and preventive strategies focused on at-risk individuals are needed. Current HF prediction models have not examined HF subtypes. We sought to develop and validate risk prediction models for HF with preserved and reduced ejection fraction (HFpEF, HFrEF).

METHODS AND RESULTS

Of 28,820 participants from 4 community-based cohorts, 982 developed incident HFpEF and 909 HFrEF during a median follow-up of 12 years. Three cohorts were combined, and a 2:1 random split was used for derivation and internal validation, with the fourth cohort as external validation. Models accounted for multiple competing risks (death, other HF subtype, and unclassified HF). The HFpEF-specific model included age, sex, systolic blood pressure, body mass index, antihypertensive treatment, and previous myocardial infarction; it had good discrimination in derivation (c-statistic 0.80; 95% confidence interval [CI], 0.78-0.82) and validation samples (internal: 0.79; 95% CI, 0.77-0.82 and external: 0.76; 95% CI: 0.71-0.80). The HFrEF-specific model additionally included smoking, left ventricular hypertrophy, left bundle branch block, and diabetes mellitus; it had good discrimination in derivation (c-statistic 0.82; 95% CI, 0.80-0.84) and validation samples (internal: 0.80; 95% CI, 0.78-0.83 and external: 0.76; 95% CI, 0.71-0.80). Age was more strongly associated with HFpEF, and male sex, left ventricular hypertrophy, bundle branch block, previous myocardial infarction, and smoking with HFrEF (P value for each comparison ≤0.02).

CONCLUSIONS

We describe and validate risk prediction models for HF subtypes and show good discrimination in a large sample. Some risk factors differed between HFpEF and HFrEF, supporting the notion of pathogenetic differences among HF subtypes.

摘要

背景

心力衰竭(HF)是一种常见的致命疾病,需要针对高危个体制定预防策略。目前的HF预测模型尚未对HF亚型进行研究。我们试图开发并验证射血分数保留型和降低型心力衰竭(HFpEF、HFrEF)的风险预测模型。

方法与结果

在来自4个社区队列的28820名参与者中,在中位随访12年期间,982人发生了HFpEF,909人发生了HFrEF。将3个队列合并,并采用2:1随机分割用于模型推导和内部验证,第4个队列作为外部验证。模型考虑了多种竞争风险(死亡、其他HF亚型和未分类的HF)。HFpEF特异性模型包括年龄、性别、收缩压、体重指数、抗高血压治疗和既往心肌梗死;其在推导样本(c统计量0.80;95%置信区间[CI],0.78 - 0.82)和验证样本(内部:0.79;95% CI,0.77 - 0.82;外部:0.76;95% CI:0.71 - 0.80)中具有良好的区分度。HFrEF特异性模型还包括吸烟、左心室肥厚、左束支传导阻滞和糖尿病;其在推导样本(c统计量0.82;95% CI,0.80 - 0.84)和验证样本(内部:0.80;95% CI,0.78 - 0.83;外部:0.76;95% CI,0.71 - 0.80)中具有良好的区分度。年龄与HFpEF的相关性更强,而男性、左心室肥厚、束支传导阻滞、既往心肌梗死和吸烟与HFrEF的相关性更强(每次比较的P值≤0.02)。

结论

我们描述并验证了HF亚型的风险预测模型,并在大样本中显示出良好的区分度。HFpEF和HFrEF之间的一些风险因素有所不同,支持了HF亚型之间存在发病机制差异的观点。

相似文献

2
Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.
Circulation. 2018 Apr 24;137(17):1814-1823. doi: 10.1161/CIRCULATIONAHA.117.031622. Epub 2018 Jan 19.
3
Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.
Circ Heart Fail. 2013 Mar;6(2):279-86. doi: 10.1161/CIRCHEARTFAILURE.112.972828. Epub 2012 Dec 27.
8
Predictors and outcomes of heart failure with mid-range ejection fraction.
Eur J Heart Fail. 2018 Apr;20(4):651-659. doi: 10.1002/ejhf.1091. Epub 2017 Dec 11.

引用本文的文献

2
Semaglutide in Heart Failure With Preserved Ejection Fraction: Emerging Evidence and Clinical Implications.
Cureus. 2025 Jul 9;17(7):e87605. doi: 10.7759/cureus.87605. eCollection 2025 Jul.
3
Demographic disparities in heart failure with preserved ejection fraction.
Heart Fail Rev. 2025 Jul 17. doi: 10.1007/s10741-025-10547-6.
5
Associations Between Urinary Metal Levels and Incident Heart Failure: A Multi-Cohort Analysis.
JACC Heart Fail. 2025 Jun 17;13(8):102510. doi: 10.1016/j.jchf.2025.03.046.
6
Impact of SGLT2 inhibitors on endothelial function and echocardiographic parameters in dilated cardiomyopathy.
J Cardiovasc Med (Hagerstown). 2025 Jun 1;26(6):284-296. doi: 10.2459/JCM.0000000000001733. Epub 2025 May 21.
7
A two-phase approach to identifying HFpEF in heart failure patients: Risk score evaluation and decision tree development.
ESC Heart Fail. 2025 Aug;12(4):3079-3085. doi: 10.1002/ehf2.15333. Epub 2025 May 28.
10
Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos.
Circ Res. 2025 May 23;136(11):1170-1207. doi: 10.1161/CIRCRESAHA.125.325602. Epub 2025 May 22.

本文引用的文献

1
Population risk prediction models for incident heart failure: a systematic review.
Circ Heart Fail. 2015 May;8(3):438-47. doi: 10.1161/CIRCHEARTFAILURE.114.001896. Epub 2015 Mar 3.
2
PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression.
Comput Methods Programs Biomed. 2015 Feb;118(2):218-33. doi: 10.1016/j.cmpb.2014.11.009. Epub 2014 Dec 3.
3
Heart failure risk prediction in the Multi-Ethnic Study of Atherosclerosis.
Heart. 2015 Jan;101(1):58-64. doi: 10.1136/heartjnl-2014-305697. Epub 2014 Nov 7.
4
Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort.
Circ Heart Fail. 2014 Sep;7(5):723-31. doi: 10.1161/CIRCHEARTFAILURE.114.001185. Epub 2014 Jul 23.
5
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验